Pharmafile Logo
Pharmafocus logo
Advanced Search
Biogen image

Pharma is boosting pipelines to avoid patent cliff

February 11, 2015
Sales and Marketing Biogen IDEC, Moody's, dimethyl fumarate, lilly, pharma, pipelines, sofosbuvir, sovaldi, tecfidera

Pharmaceutical companies have improved their pipelines of new drugs over the last 18 months according to financial analysts Moody’s Investors …

News

US measles outbreak worst for 15 years

February 11, 2015
Sales and Marketing FDA, cdcp, hamburg, measles, priorix, trimovax, vaccines

The worst measles outbreak in 15 years has reached a startling 121 cases in the US alone according to the …

News
GSK vaccine image

GSK buys bacteria vaccine firm

February 11, 2015
Research and Development, Sales and Marketing EC, GSK, GlaxoSmithKline, GlycoVaxyn, Novartis, vaccines

GlaxoSmithKline is continuing the significant expansion of its vaccine business with the purchase of Swiss biopharma company GlycoVaxyn. The UK …

News
edward_bliss

MRC Technology hires senior head from Shire

February 11, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Edward Bliss, MRC, Shire

UK medical research charity MRC Technology has appointed Dr Edward Bliss to the new role of general counsel and company …

Appointment
Pharma image

Pharma’s reputation ‘is worsening among patients’

February 10, 2015
Medical Communications, Research and Development, Sales and Marketing HIV, ViiV Healthcare, patientview, pharma, reputation, transparency

Only around four in ten patients believe pharma has a good reputation and many companies are failing to win patient …

News
Doctors image

Charity challenges Sovaldi patent

February 10, 2015
Sales and Marketing Gilead, HCV, Médecins du Monde, sofosbuvir, sovaldi, world health organization

Doctors of the World (also known as Médecins du Monde) has filed an opposition to the patent for Gilead’s blockbuster …

News
Gilead image

Gilead expands UK presence with new London HQ

February 10, 2015
Research and Development, Sales and Marketing Cambridge, Gilead, London, NICE, UK, johnson, medcity, sovaldi, uxbridge

Gilead is to create a new UK commercial secondary headquarters in central London doubling its UK workforce to 600 by …

News
GSK image

Second late-stage COPD trial for GSK and Theravance

February 10, 2015
Sales and Marketing COPD, FF/UMEC/VI, GSK, Theravance, fluticasone furoate, umeclidinium, vilanterol

GlaxoSmithKline and Theravance have begun a second Phase III trial of their investigational triple combination COPD drug as the former …

News
Propofol image

Hospira recalls Propofol drug again

February 10, 2015
Manufacturing and Production, Sales and Marketing Hospira, Pfizer, diprivan, manufacturing, merger, propofol

Hospira has issued a recall of anaesthesia support drug Propofol after the neck of one vial was revealed to contain …

News
erik_nordkamp_

Pfizer replaces UK managing director

February 10, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Erik Nordkamp, Pfizer, jonathan emms

Erik Nordkamp has been named as the managing director of Pfizer UK to take over from Jonathan Emms. Emms has …

Appointment
Manufacturing image

MHRA shuts down unlicensed cancer drug facility

February 9, 2015
Manufacturing and Production, Sales and Marketing Cambridge, GcMAF, MHRA, first immune, globulin component macrophage activating factor

The MHRA has shut down an unlicensed Cambridgeshire plant that was producing a potentially dangerous drug to be sold online. …

News
Kearney image

New president for ABPI

February 9, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Amgen, Pfizer, Whitehead, emms, john kearney

The Association of the British Pharmaceutical Industry has appointed John Kearney as its new president. Stepping into the role in …

News
Roche image

FDA clears Roche eye drug

February 9, 2015
Sales and Marketing AMD, DME, FDA, Lucentis, Retina, Roche, eyes, ranibizumab

The US Food and Drug Administration has shown Roche’s eye-condition drug Lucentis the green light to treat patients with diabetic …

News
Financial image

Financial round-up: how has pharma fared in 2014?

February 9, 2015
Medical Communications, Research and Development, Sales and Marketing

A select look at the latest figures and performance from some of the industry’s big players:MerckQuarter four 2014 sales Sales of …

News
peter_adorjan

Centogene appoints chief business officer

February 9, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Péter Adorján, centogene

Dr Péter Adorján has been appointed to the board of German rare disease firm Centogene and thereby extending its board …

Appointment
Campbell image

Changing our minds about depression

February 9, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Campbell, Lamb, Lundbeck, depression, economist, mind

Alastair Campbell, former Labour spin doctor and depression patient, thinks that mental and physical health should not be seen as …

Feature
Sanofi image

Sanofi sales lifted by diabetes and rare diseases

February 6, 2015
Sales and Marketing Genzyme, Lantus, Sanofi, diabetes, financials, insulin glargine, praluent, q4

Sanofi racked up €7.4 billion in sales in the fourth quarter of 2014 according to the company’s latest financials report. …

News
NHS image

NHS reform was ‘distracting and damaging’

February 6, 2015
Sales and Marketing CDF, Cameron, NHS, UK, coalition, healthcare, king's fund

Healthcare think tank The King’s Fund has said through a report that organisational changes to the NHS under the coalition …

News
AZ image

AstraZeneca looks for revenue boost via Actavis buy

February 6, 2015
Sales and Marketing Actavis, AstraZeneca, Brilinta, Forxiga, diabetes, fourth quarter, q4

AstraZeneca recorded a dip in revenue in the last quarter of 2014 and is looking to ramp up its respiratory …

News
flu image

Flu vaccine ineffective against this season’s strain

February 6, 2015
Research and Development, Sales and Marketing A(H3N2, Public Health England, UK, Vaccine, WHO, flu, phe

This season’s flu vaccine has provided little protection against the main strain circulating in the UK according to a new …

News
The Gateway to Local Adoption Series

Latest content

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026

Incyclix Bio announces new additions to the Board

April 22, 2026

Remedy Plan Therapeutics Appoints Jotin Marango as CFO and CBO

April 21, 2026